← Back to catalogue

Aptima®

FDA UDI

Class II (US FDA UDI)

by Hologic, Inc.

Identity

Trade Name
Aptima® FDA UDI
Generic Name
HIV1/Hepatitis C virus/Hepatitis B virus nucleic acid IVD, reagent FDA UDI
Device Name
Aptima® HBV Quant Assay Target Enhancer Reagent. FDA UDI
Model / Reference
KIT, TER, HBV, VL, 100T, US IVD FDA UDI
Description
Aptima® HBV Quant Assay Target Enhancer Reagent. FDA UDI

Identifiers

Catalog Number
PRD-04081 FDA UDI
Primary DI / UDI-DI
15420045506770 FDA UDI
PMA Number
P170025 FDA UDI
FDA Product Code
MKT FDA UDI
GMDN Term
HIV1/Hepatitis C virus/Hepatitis B virus nucleic acid IVD, reagent FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3174 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: HIV1/Hepatitis C virus/Hepatitis B virus nucleic acid IVD, reagent

Aptima® by Hologic, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Hologic, Inc.

Sources (1)

  • FDA UDI 76406bb6-a6b8-47bb-bdac-d4b8a5493454 37 fields · synced May 31, 2026